Vulnerable species — and the impact of the facility on their habitat and well-being — are at the core of a legal fight.

AT SIX. AND NEW AT SIX. A KITESURFER RESCUED OFF GRAVES LIGHT AND A CHANCE ENCOUNTER SAVED HIS LIFE. LET’S GET TO NEWSCENTER 5 JOHN ATWATER. HE SPOKE WITH HIM. HE JOINS US LIVE FROM EAST BOSTON RIGHT ...

Gilead Sciences has bolstered its position in the development of next-generation cancer cell therapies with a deal to absorb Tmunity Therapeutics into its Kite unit. Kite has agreed to acquire all the ...

SANTA MONICA, Calif. & PHILADELPHIA--(BUSINESS WIRE)--Kite, a Gilead Company (Nasdaq: GILD), today announced that it has entered into a definitive agreement to acquire Interius BioTherapeutics, a ...

Gilead Sciences has become the latest pharma to strengthen its in vivo cell therapy credentials this year, paying $350 million for CAR-T developer Interius BioTherapeutics. Integrating Interius into ...

SANTA MONICA, Calif. & PHILADELPHIA, August 21, 2025--(BUSINESS WIRE)--Kite, a Gilead Company (Nasdaq: GILD), today announced that it has entered into a definitive agreement to acquire Interius ...

The Kerala Infrastructure and Technology for Education (KITE) has integrated animation, visual effects, gaming and comics (AVGC) into its school ICT textbooks for all students. This follows the ...

A free two-day event coming to scenic rural Ontario is melding classic festival offerings like food, vendors and live music with something you won't find anywhere else: a kite show featuring some of ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

Kite, a Gilead Company (Nasdaq: GILD), today announced that it has entered into a definitive agreement to acquire Interius BioTherapeutics, a privately held ...

Ole Miss is hoping veteran CB Antonio Kite can be a part of the solution in the defensive backfield for the Rebels in 2025. OXFORD | Ole Miss' secondary is among the position units with the most ...

Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ...